{"id":"W2082686341","doi":"10.2165/00002018-200629010-00004","title":"Fulfilling an Unmet Need in Psoriasis","year":2006,"lang":"en","type":"review","venue":"Drug Safety","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":39,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Psoriasis; Medicine; Efalizumab; Etanercept; Adalimumab; Infliximab; Rheumatoid arthritis; Methotrexate; Dermatology; Psoriatic arthritis; Acitretin; Immunology; Ciclosporin; Population; Tumor necrosis factor alpha; Transplantation; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005891573,0.0006652316,0.00208773,0.0004542257,0.0001733822,0.00002051608,0.000475393,0.0008946158,0.0004425482],"category_scores_gemma":[0.00003296007,0.0005458844,0.0006047756,0.0005402933,0.00008201801,0.0001068893,0.00008664742,0.0004975634,0.00121384],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002223466,"about_ca_system_score_gemma":0.000188302,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005093252,"about_ca_topic_score_gemma":0.0004044889,"domain_scores_codex":[0.9966379,0.001023964,0.0009594324,0.0007191767,0.00005061276,0.0006088914],"domain_scores_gemma":[0.9985037,0.0003914684,0.0003523687,0.0006834868,0.00003151333,0.00003744814],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000463617,0.0001992796,0.00005129807,0.0007928994,0.0003222944,0.00002992077,0.0001313046,0.000003098103,0.000005032849,0.0002061408,0.001044282,0.9971681],"study_design_scores_gemma":[0.001036336,0.0000326632,0.000108498,0.001506054,0.0009958204,0.00004390913,0.00005841268,3.969055e-7,0.0000236458,0.00004173375,0.9955935,0.000558992],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002098831,0.9934833,0.00001234375,0.00001773605,0.001731975,0.0006350541,0.0005372769,0.0001243751,0.003248037],"genre_scores_gemma":[0.0001147867,0.9880962,0.0001379616,0.00002199332,0.0002209333,0.0001190911,0.006322709,0.00007914598,0.004887137],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9966091,"threshold_uncertainty_score":0.9996993,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03132901714524539,"score_gpt":0.2907435946833291,"score_spread":0.2594145775380837,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}